SYAB.DE
Price:
$11.06
Market Cap:
$2.43B
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Industry
Medical - Diagnostics & Research
IPO Date
2021-04-30
Stock Exchange
XETRA
Ticker
SYAB.DE
According to SYNLAB AG’s latest financial reports and current stock price. The company's current ROE is 3.25%. This represents a change of 258.04% compared to the average of 0.91% of the last 4 quarters.
The mean historical ROE of SYNLAB AG over the last ten years is 21.41%. The current 3.25% ROE has changed -84.82% with respect to the historical average. Over the past ten years (40 quarters), SYAB.DE's ROE was at its highest in in the December 2020 quarter at 29.13%. The ROE was at its lowest in in the March 2022 quarter at -16.37%.
Average
21.41%
Median
3.15%
Minimum
-25.31%
Maximum
148.78%
Discovering the peaks and valleys of SYNLAB AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 779.66%
Maximum Annual ROE = 148.78%
Minimum Annual Increase = -191.42%
Minimum Annual ROE = -25.31%
Year | ROE | Change |
---|---|---|
2023 | 3.94% | -115.58% |
2022 | -25.31% | -191.42% |
2021 | 27.68% | 779.66% |
2020 | 3.15% | -124.51% |
2019 | -12.84% | 162.57% |
2018 | -4.89% | -67.88% |
2017 | -15.22% | -122.58% |
2016 | 67.43% | -54.68% |
The current ROE of SYNLAB AG (SYAB.DE) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
2.11%
5-year avg
-0.67%
10-year avg
21.41%
SYNLAB AG’s ROE is greater than SUSE S.A. (-1.78%), less than Dermapharm Holding SE (19.61%), greater than Shop Apotheke Europe N.V. (-9.16%), less than Hensoldt AG (13.82%), less than Traton SE (16.33%),
Company | ROE | Market cap |
---|---|---|
-1.78% | $1.85B | |
19.61% | $2.09B | |
-9.16% | $1.61B | |
13.82% | $7.40B | |
16.33% | $14.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SYNLAB AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SYNLAB AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is SYNLAB AG's ROE?
How is the ROE calculated for SYNLAB AG (SYAB.DE)?
What is the highest ROE for SYNLAB AG (SYAB.DE)?
What is the 3-year average ROE for SYNLAB AG (SYAB.DE)?
What is the 5-year average ROE for SYNLAB AG (SYAB.DE)?
How does the current ROE for SYNLAB AG (SYAB.DE) compare to its historical average?